OBJECTIVES: To evaluate clinical and imaging features of cancer recurrence in reconstructed breasts following skin-sparing mastectomy (SSM) or nipple areolar skin-sparing mastectomy (NASSM). METHODS: This study was approved by our Institutional Review Board. In this retrospective study, we included patients with pathologically confirmed recurrent cancer who had transverse rectus abdominis myocutaneous (TRAM) flap reconstruction after SSM or NASSM and whose follow-up radiological studies were available. Each patient's demographic data, imaging studies and clinical outcomes were reviewed. Two breast radiologists analysed the imaging findings of follow-up mammography, ultrasound and magnetic resonance imaging. RESULTS: Of the 964 patients, 16 (1.7%) had local cancer recurrence. The average follow-up period until the detection was 31.1 months (range, 7-84 months). Fourteen (87.5%) patients had recurrence on the skin or in subcutaneous fat. Of the 16 patients, recurrence was detected by breast self-examination in 13 (81.3%) patients. Eight (50%) lesions mimicked benign lesions. The other eight (50%) lesions manifested various degree of suspicion for the malignancy. CONCLUSIONS: Recurrent cancer after TRAM flap reconstruction following SSM and NASSM is often recognised by breast self-examination and mimics imaging findings of benign lesions. Therefore, meticulous physical examination and history-taking are important. Pathological confirmation is worthwhile even in the benign-appearing lesions. KEY POINTS: Overview of clinical and imaging features of cancer recurrence in reconstructed breasts. 50% of recurred malignant lesions mimicking imaging findings of benign lesions. Patients may benefit from thorough self-breast examination.
OBJECTIVES: To evaluate clinical and imaging features of cancer recurrence in reconstructed breasts following skin-sparing mastectomy (SSM) or nipple areolar skin-sparing mastectomy (NASSM). METHODS: This study was approved by our Institutional Review Board. In this retrospective study, we included patients with pathologically confirmed recurrent cancer who had transverse rectus abdominis myocutaneous (TRAM) flap reconstruction after SSM or NASSM and whose follow-up radiological studies were available. Each patient's demographic data, imaging studies and clinical outcomes were reviewed. Two breast radiologists analysed the imaging findings of follow-up mammography, ultrasound and magnetic resonance imaging. RESULTS: Of the 964 patients, 16 (1.7%) had local cancer recurrence. The average follow-up period until the detection was 31.1 months (range, 7-84 months). Fourteen (87.5%) patients had recurrence on the skin or in subcutaneous fat. Of the 16 patients, recurrence was detected by breast self-examination in 13 (81.3%) patients. Eight (50%) lesions mimicked benign lesions. The other eight (50%) lesions manifested various degree of suspicion for the malignancy. CONCLUSIONS: Recurrent cancer after TRAM flap reconstruction following SSM and NASSM is often recognised by breast self-examination and mimics imaging findings of benign lesions. Therefore, meticulous physical examination and history-taking are important. Pathological confirmation is worthwhile even in the benign-appearing lesions. KEY POINTS: Overview of clinical and imaging features of cancer recurrence in reconstructed breasts. 50% of recurred malignant lesions mimicking imaging findings of benign lesions. Patients may benefit from thorough self-breast examination.
Authors: S S Kroll; A Khoo; S E Singletary; F C Ames; B G Wang; G P Reece; M J Miller; G R Evans; G L Robb Journal: Plast Reconstr Surg Date: 1999-08 Impact factor: 4.730
Authors: Michael A Howard; Kristen Polo; Andrea L Pusic; Peter G Cordeiro; David A Hidalgo; Babak Mehrara; Joseph J Disa Journal: Plast Reconstr Surg Date: 2006-04-15 Impact factor: 4.730
Authors: Heriberto Medina-Franco; Luis O Vasconez; R Jobe Fix; Martin J Heslin; Samuel W Beenken; Kirby I Bland; Marshall M Urist Journal: Ann Surg Date: 2002-06 Impact factor: 12.969
Authors: Joseph J Disa; Peter G Cordeiro; Alexandra H Heerdt; Jeanne A Petrek; Patrick J Borgen; David A Hidalgo Journal: Plast Reconstr Surg Date: 2003-01 Impact factor: 4.730
Authors: Howard N Langstein; Ming-Huei Cheng; S Eva Singletary; Geoffrey L Robb; Emma Hoy; Terry L Smith; Stephen S Kroll Journal: Plast Reconstr Surg Date: 2003-02 Impact factor: 4.730
Authors: Thomas Hehr; René Baumann; Wilfried Budach; Marciana-Nona Duma; Jürgen Dunst; Petra Feyer; Rainer Fietkau; Wulf Haase; Wolfgang Harms; David Krug; Marc D Piroth; Felix Sedlmayer; Rainer Souchon; Frederick Wenz; Rolf Sauer Journal: Strahlenther Onkol Date: 2019-08-26 Impact factor: 3.621
Authors: Rend Al-Khalili; Ali Alzeer; Giang-Kimthi Nguyen; Erin P Crane; Judy H Song; Janice L Jeon; Michael Nellamattathil; Erini V Makariou; Victoria L Mango Journal: Radiographics Date: 2021-05-14 Impact factor: 6.312
Authors: R A Agha; Y Al Omran; G Wellstead; H Sagoo; I Barai; S Rajmohan; M R Borrelli; M Vella-Baldacchino; D P Orgill; J E Rusby Journal: BJS Open Date: 2018-12-19